Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
Effects of Metformin and Combination of Metformin and Pioglitazone on Plasma Interleukin-6 and Interleukin-8 Levels in Polycystic Ovarian Syndrome
Sponsor: Khyber Medical University Peshawar
A EARLY_PHASE1 clinical study on Polycystic Ovarian Syndrome, this trial is completed. The trial is conducted by Khyber Medical University Peshawar and has accumulated 11 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed EARLY_PHASE1
-
Dec 2021 — Dec 2022 [monthly]
Completed EARLY_PHASE1
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed EARLY_PHASE1
-
Apr 2020 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Jun 2018 — Apr 2020 [monthly]
Completed EARLY_PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Completed EARLY_PHASE1
Status: Recruiting → Completed
-
Oct 2017 — Mar 2018 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2017 — Oct 2017 [monthly]
Recruiting EARLY_PHASE1
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Khyber Medical University Peshawar
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Mardan, Pakistan